Acurx Pharmaceuticals, Inc. Shareholders' Equity
Acurx Pharmaceuticals, Inc. (ACXP) had Shareholders' Equity of $8.15 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $8.15M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $7.01M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.27M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.64M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $8.15M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $7.01M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $5.27M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $3.64M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.57M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $2.31M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $615.12K 10-Q · filed 2026-08-13 |
| 2024-09-30 | $2.66M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $3.43M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $6.00M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $4.67M 10-K · filed 2026-03-12 |
| 2023-09-30 | $3.93M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $6.22M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $5.31M 10-Q · filed 2024-11-12 |
| 2022-12-31 | $7.32M 10-K · filed 2025-03-17 |
| 2022-09-30 | $9.76M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $8.79M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $10.69M 10-Q · filed 2023-11-13 |
| 2021-12-31 | $12.41M 10-K · filed 2024-03-15 |
| 2021-09-30 | $14.28M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $15.52M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $2.47M 10-Q · filed 2022-11-10 |
| 2020-12-31 | $2.70M 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |